Results
|
|
1701.
|
|
|
|
1702.
|
|
|
|
1703.
|
|
|
|
1704.
|
|
|
|
1705.
|
|
|
|
1706.
|
|
|
|
1707.
|
How do CYP2C19*2 and CYP2C19*17 genetic polymorphisms affect the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome? [electronic resource] by
- Skryabin, Valentin Yu
- Zastrozhin, Mikhail S
- Torrado, Marco V
- Grishina, Elena A
- Ryzhikova, Kristina A
- Shipitsyn, Valery V
- Galaktionova, Tatiana E
- Sorokin, Alexander S
- Bryun, Evgeny A
- Sychev, Dmitry A
Producer: 20210707
In:
Drug metabolism and personalized therapy vol. 35
Availability: No items available.
|
|
|
1708.
|
Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease. [electronic resource] by
- Sychev, Dmitriy
- Skripka, Alena
- Ryzhikova, Kristina
- Bochkov, Pavel
- Shevchenko, Roman
- Krupenin, Pavel
- Ivashchenko, Dmitriy
- Kogay, Veronika
- Listratov, Alexander
- Krainyaya, Arina
- Gurinovich, Olga
- Sokolova, Anastasiya
- Napalkov, Dmitriy
- Fomin, Viktor
Producer: 20210707
In:
Drug metabolism and personalized therapy vol. 35
Availability: No items available.
|
|
|
1709.
|
|
|
|
1710.
|
|
|
|
1711.
|
|
|
|
1712.
|
|
|
|
1713.
|
|
|
|
1714.
|
|
|
|
1715.
|
|
|
|
1716.
|
|
|
|
1717.
|
|
|
|
1718.
|
|
|
|
1719.
|
|
|
|
1720.
|
|